Also known as Cranial Neuropathy and Cranial Nerve Disease
Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.Source: MeSH
Within all the people who go to their doctor with cranial nerve palsy, 53% report having double vision, 40% report having headache, and 35% report having diminished vision. The symptoms that are highly suggestive of cranial nerve palsy are double vision, symptoms of the face, abnormal movement of eyelid, and pupils unequal, although you may still have cranial nerve palsy without those symptoms.
Patients with cranial nerve palsy often receive magnetic resonance imaging, other diagnostic procedures (interview; evaluation; consultation), ophthalmic examination and evaluation, ophthalmologic and otologic diagnosis and treatment, other therapeutic procedures, cat scan of head, other therapeutic procedures on eyelids; conjunctiva; cornea and occupational therapy assessment .
|Magnetic resonance imaging (Mri)||$297|
|Other diagnostic procedures (interview; evaluation; consultation)||$101|
|Ophthalmic examination and evaluation (Eye exam)|
|Ophthalmologic and otologic diagnosis and treatment||$64|
|Other therapeutic procedures||$17|
|CAT scan of head (Head ct)|
|Other therapeutic procedures on eyelids; conjunctiva; cornea||$962|
|Occupational therapy assessment (Speech therapy)|
The most commonly prescribed drugs for patients with cranial nerve palsy include botulinum toxin type a (botox), botulism antitoxin, pseudoephedrine / triprolidine, cyclopentolate ophthalmic, olopatadine ophthalmic, pergolide, mumps vaccine, rimabotulinumtoxinb (myobloc), desloratadine / pseudoephedrine, erythromycin topical product, measles vaccine, rubella virus vaccine and tegaserod (zelnorm) .
Groups of people at highest risk for cranial nerve palsy include age 5-14 years age < 1 years.